Post hoc analysis of the interventional management of stroke III trial (a multicenter phase 3 trial of 900 subjects evaluating treatment with low-dose IV tPA plus thrombectomy or IV tPA alone) highlighted the crucial role of collateral circulation status for clinical outcome. The gene discussed is PLAT; the disease is stroke disorder.